Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Olomorasib shows durable first-line activity in KRAS G12C-mutant lung cancer


Incyte reports new KRAS G12D and bispecific antibody data across pancreatic and colorectal cancer


Jemperli achieves 76% complete response rate in Phase II rectal cancer trial


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Points to consider when defining a microbial control strategy for individualized ATMPs

Presented by Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy)
05th April 2023


The Importance of Accurate Chemical Characterization of Medical Devices Extractables

Presented by Ron Brown, Toxicologist at Risk Science Consortium and Piet Christiaens, PhD, Scientific Director at Nelson Labs
16th November 2022


From Early Stage to Late Stage Development: How to Characterize a Perfusion-based Vaccine Production Process Using QbD?

Presented by Perrine Rouel, Scientist - Up Stream Processing, The Janssen Pharmaceutical Companies of Johnson & Johnson and Tom Jeffery, Application Specialist – Ambr Technology KAM Europe at Sartorius Stedim Biotech
27th March 2019


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia